4-(4-Aminophenoxy)-N-Methylpicolinamide CAS 284462-37-9
Commercial Supple Sorafenib Tosylate et intermedia:
Sorafenib Tosylate CAS: 475207-59-1
Sorafenib CAS: 284461-73-0
4-Chloro-N-Methyl-2-Pyridinecarboxamide CAS: 220000-87-3
4-(4-Aminophenoxy)-N-Methylpicolamide CAS:
4-Chloro-3-(Trifluoromethyl) phenyl Isocyanate CAS: 327-78-6
Nomen chemicum | 4-(4-Aminophenoxy) -N-Methylpicolamide |
Synonyma | 4-(4-Aminophenoxy) -N-Methyl-2-pyridinecarboxamide |
CAS Number | 284462-37-9 |
CATTUS Number | RF-PI166 |
Stock Status | In Stock, Productio Ascendite ad Tons |
Formulae hypotheticae | C13H13N3O2 |
M. Pondus | 243.27 |
Liquescens punctum | 110.0~112.0℃ |
Density | 1.241 g/cm3 |
Brand | Ruifu Chemical |
Item | Specifications |
Aspectus | Lux Brown ad Off-White pulveris |
Puritas / Analysis Methodus | 98.0%~ 101.0% (ex sicca basis) (HPLC) |
Damnum in Siccatio | ≤0.50% |
Residere in Ignition | ≤0.20% |
una immunditia | ≤0.20% |
Summa immunditiae | ≤1.0% |
Metalla gravis | ≤20ppm |
Test Standard | Enterprise Standard |
Consuetudinem | Intermedia Sorafenib Tosylate (CAS: 475207-59-1) |
sarcina: Utrem, aluminium foil, pera, cardboard tympanum, 25kg/Drum, vel secundum exigentiam emptoris.
Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine, umore et peste infestatione.
![1](https://www.ruifuchemical.com/uploads/15.jpg)
![](https://a395.goodao.net/uploads/23.jpg)
Manufacturer cum High puritate et stabulo Quality
Supple Commercial Sorafenib Tosylate (CAS: 475207-59-1) Intermedia:
Sorafenib Tosylate CAS: 475207-59-1
Sorafenib CAS: 284461-73-0
4-Chloro-N-Methyl-2-Pyridinecarboxamide CAS: 220000-87-3
4-(4-Aminophenoxy)-N-Methylpicolamide CAS:
4-Chloro-3-(Trifluoromethyl) phenyl Isocyanate CAS: 327-78-6
Sorafenib Tosylate (CAS: 475207-59-1) est novum genus pharmaci antitumoris multi-scopi, a Germanico Bayer pharmaceutico enucleatum, et in experimentis animali preclinicis antitumorem expansivum ostendit.Sorafenib praesto est in tabulis CC-mg pro administratione oralis adhibenda in curatione RCC et HCC.